Managing patients with type 2 diabetes according to the latest guidelines

2020-04-17

Chantal Mathieu

Dr Chantal Mathieu is a professor of medicine at KU Leuven (Belgium) and chair in the Division of Endocrinology at UZ Leuven.

See also

Changes in the management of type 2 diabetes (2018 consensus) What is the most important change in the management of type 2 diabetes according to the 2018 consensus report by the American Diabetes Association (ADA) and the European Association of the Study of Diabetes (EASD)?
Current management of obesity A lecture by Dr Dror Dicker, from Tel Aviv University, Israel, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Biologics in systemic autoimmune diseases A lecture by Dr Bhaskar Dasgupta, from Southend University Hospital, UK, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Management of patients with thyroid emergencies in the ICU Should patients with thyroid emergencies (myxedema coma, thyroid storm) be treated in the intensive care unit (ICU)? What parameters and laboratory tests should be monitored?
Sulfonylureas in diabetes Is there still a place for sulfonylureas in the management of older patients with diabetes?
When to use insulin in type 2 diabetes A lecture by Dr René Rodríguez-Gutiérrez, from Mayo Clinic, USA, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.